1.220USD+1.67%Mkt Cap: 107.36M USDP/E: —Last update: 2026-05-26
Vivani Medical, Inc., a clinical-stage biopharmaceutical company, engages in the development of miniaturized and subdermal drug implants that treat chronic diseases. The company uses its NanoPortal implant technology to …
Industry Peers
Biotechnology110.61BUSDP/E 25.8
106.49BDKKP/E 20.5
66.47BUSDP/E 15.5
46.51BEURP/E 30.5
43.17BEURP/E 35.9
39.41BUSDP/E 74.0
32.84BUSD—
31.18BSEKP/E 46.1
Indicators:|
Key Statistics
Company
Market Cap107.36M USD
Enterprise Value98.56M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-26.61M USD
Revenue/Share—
Last Price1.220 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees42
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-3.31
PEG—
EV/EBITDA-3.60
EV/Revenue—
P/S—
P/B5.16
EPS (TTM)-0.40
EPS (Forward)-0.35
52W Range
0.923030% of range1.920
52W High1.920 USD
52W Low0.9230 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-169.16%
ROA-67.55%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-24.32M USD
CapEx (TTM)1.17M USD
FCF Margin—
FCF Yield-15.25%
Net Debt-1.47M USD
Net Debt/EBITDA0.05
Balance Sheet
Debt/Equity1.20
Current Ratio3.18
Quick Ratio3.02
Book Value/Sh0.2250 USD
Cash/Share0.2290 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateJan 6, 2020
Splits
Last Split1:3
Split DateAug 19, 2022
Analyst Consensus
Rating1.3 (Strong Buy)
Target (Mean)4.833 USD
Target Range3.500 USD – 7.000 USD
# Analysts3
Ownership
Shares Out.86.24M
Float38.86M
Insiders57.94%
Institutions6.50%
Short Interest
Short Ratio1.1d
Short % Float0.81%
Short % Out.0.41%
Shares Short350.95K
Short (prev mo.)532.13K
Technical
SMA 501.186 (+2.9%)
SMA 2001.316 (-7.3%)
Beta—
S&P 52W Chg28.31%
Avg Vol (30d)296.26K
Avg Vol (10d)208.25K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—